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Abstract: 
In this research, twenty nine analogues having variable inhibition of E.coli were subjected to quantitative structure 
activity relationship analysis. Various thermodynamic, electronic and steric parameters were calculated using 
Chem 3D package of molecular modeling software Chemoffice 8.0. QSAR models were generated employing 
sequential multiple regression method using in–house statistical program VALSTAT. Statistically significant models 
with R–values 0.90 were obtained. Models were validated using leave one out and bootstrapping methods. Results 
obtained shows that stretch energy, dipole-dipole energy, HOMO energy and Non-1, 4 VDW Energy are 
contributing to biological activity. Findings of present study reveal that substituent those decrease the flexibility of 
molecule results in increase in antimicrobial potency, aryl substituent would enhance the antimicrobial activity of 
compounds and presence of electron withdrawing group in structure is favorable for antibacterial activity of 
triazolothiadiazoles. 
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INTRODUCTION: 
Triazolothiadiazole system may be viewed as a cyclic 
analogue of two very important compound [1]. 
Thiosemicarbazide and biguanide/thioguanide which 
often display diverse   biological activity [2]. More 
over the triazolothiadiazole substituted in the 3 and 6 
positions by aryl, alkyl or heterocyclic moiety 
possess pharmacological activities[3-6] such as anti- 
bacterial, anti-fungal activity, anti- viral activity, anti-
inflammatory, and analgesic, herbicidal and anti- 
HIV-1 effects. 1, 2, 4-triazole and 1, 3, 4-triazoles 
represent one of the most biologically active classes 
of compounds, possessing a wide spectrum of 
activities. A literature, survey indicated that 1, 2, 4-
triazole and 1, 3, 4-triazole thiadiazloes derivatives 
play vital role as synthetic drugs. These observations 
led to the conception that triazolothiadiazole 
derivatives would possess potential antimicrobial 
properties. This Quantitative structure–activity 
relationship (QSAR) study enables the investigators 
to establish a reliable quantitative structure–activity 
and structure–property relationships to derive a 
QSAR model to predict the activity of novel 
molecules prior to their synthesis [7]. A data set of 29 
molecules exhibiting potent antibacterial activity 
against E. coli has been taken from published article 
of T. Karabasanagouda et.al [8] and S N Swamy et al 
[9]. The overall process of QSAR model 
development can be divided into three stages namely, 
the data preparation, data analysis, and model 
validation, representing a standard practice of any 
QSAR modeling [10-16]. In this research, an attempt 
has been made to describe the Quantitative structure–
activity Relationship (QSAR) analysis of 
triazolothiadiazole derivatives to study and deduce a 
correlation between structure and antimicrobial 
activity of these derivatives. 
 
MATERIALS AND METHODS: 
A data set of 29 molecules exhibiting potent 
antibacterial activity against E. coli has been taken 
from published article of T. Karabasanagouda et al 
and S N Swamy et al. All the values of biological 
data were shown in MIC (µg/ml), which were 
converted into –logMIC (µg/ml) for convenience of 
computational work. Structures of reported 
compounds and Pmic values are shown in Table-
1.QSAR study was done on these 29 compounds.  
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Table 1:  Structure of triazolothiadiazole derivatives along with their MIC and PMIC values: 
 
 
Comp. No. Ar Ar’ MIC Pmic 
1.  CH2OC6H4SCH3 C6H5 6.25 7.75 
2.  CH2OC6H4SCH3 2-ClC6H4 25 7.17 
3.  CH2OC6H4SCH3 4-CH3C6H4 6.25 7.77 
4.  CH2OC6H4SCH3 4-OCH3C6H4 6.25 7.79 
5.  CH2OC6H4SCH3 4-NH2C6H4 6.25 7.77 
6.  CH2OC6H4SCH3 2,3-(Cl)2C6H4 6.25 7.83 
7.  CH2OC6H4SCH3 C6H5CH2 6.25 7.77 
8.  CH2OC6H4SC2H5 C6H5 6.25 7.77 
9.  CH2OC6H4SC2H5 2-ClC6H4 25 7.21 
10.  CH2OC6H4SC2H5 4-CH3C6H4 6.25 7.79 
11.  CH2OC6H4SC2H5 4-OCH3C6H4 25 7.20 
12.  CH2OC6H4SC2H5 4-NH2C6H4 25 7.19 
13.  CH2OC6H4SC2H5 2,3-(Cl)2C6H4 25 7.24 
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14.  CH2OC6H4SC2H5 2-OHC6H4 25 7.19 
15.  CH2OC6H4SO2CH3 C6H5 12.5 7.49 
16.  CH2OC6H4SO2CH3 2-ClC6H4 12.5 7.53 
17.  CH2OC6H4SO2CH3 3-ClC6H4 12.5 7.53 
18.  CH2OC6H4SO2CH3 C6H5CH2 12.5 7.51 
19.  CH2OC6H4SO2CH3 2,3-(Cl)2C6H4 6.25 7.86 
20.  CH3 C6H4Cl 41 6.79 
21.  C2H5 C6H4Cl 13 7.31 
22.  C6H5 C6H4Cl 15 7.32 
23.  4-CH3C6H5 C6H4Cl 17 7.28 
24.  4-Cl-C6H5 C6H4Cl 40 6.94 
25.  CH3 C3H7 39 6.79 
26.  C2H5 C3H7 12 7.32 
27.  C6H5 C3H7 14 7.33 
28.  4-CH3C6H5 C3H7 15 7.32 
29.  4-Cl-C6H5 C3H7 38 6.95 
 
Methodology and software used for QSAR 
analysis: 
The molecular modeling study was performed using 
CS Chemoffice 2004 and regression analysis was 
carried out on VALSTAT. The compounds in the 
series were sketched using ChemDraw module of 
ChemOffice. The sketched structures  were subjected 
to energy minimization using Allinger’s MM2 force 
field followed by semi empirical AM1 (Austin 
Model) Hamiltonian method available in MOPAC 
module by fixing root mean square gradient as 0.1 
and 0.0001kcal/Mol A˚ respectively. The values of 
descriptor (like thermodynamic, steric and 
electronic,) for all the molecules were calculated 
using “compute properties” module of Chemultra. 
The calculated values were then tabulated along with 
biological activity. The QSAR models were 
generated using biological activity as dependent 
variable and descriptors as independent variables. In 
the present study, sequential multiple linear 
regression analysis was performed to generate 
various equations which were further validated by 
most popular leave one out (LOO) cross-validation 
method to ensure their robustness. The generated 
QSAR models were validated for predictive ability 
inside the model (Leave one out method) using 
VALSTAT. The statistical program which is tailored 
specifically for QSAR statistics estimates the 
predictive potential of model by calculating the 
validation parameters squared cross–correlation 
coefficient (q2), standard deviation of sum of square 
of difference between predicted and observed values 
(SPRESS) and standard deviation of error of 
prediction (SDEP). 
 
Table 2: Calculated substituent constants used in 3D-QSAR analysis of triazolothiadiazoles: 
Comp. No Stretch 
Energy(Q) 
Dipole-dipole 
energy (R) 
HOMO 
Energy(AE) 
Non-1,4 VDW 
Energy(AF) 
1.  16.14 -4.17 -8.01 -1.18 
2.  8.39 -2.26 -8.10 2.33 
3.  15.99 -4.18 -8.05 -0.68 
4.  16.56 -4.19 -8.05 0.25 
5.  19.18 -4.12 -7.91 -0.43 
6.  16.45 -4.18 -8.08 11.05 
7.  15.89 -4.14 -7.97 -2.80 
8.  15.47 -4.27 -7.96 -0.17 
9.  12.74 -3.06 -8.35 1.24 
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RESULTS AND DISCUSSION: 
Biological activity data and various physicochemical 
parameters were taken as dependent and independent 
variables respectively and correlations were 
established using sequential multiple regression 
analysis. The descriptors selected for modeling 
antibacterial activity of triazolothiadiazoles are 
summarized in Table 2. Among the many 
correlations generated, two best models were selected 
on the basis of statistical significance. The best 
models obtained are given below along with their 
statistical measures. 
 
Model 1: 
Parent equation: 
BA = [6.24186( ± 0.261315)] +Q [0.0654959( ± 
0.01742)] +R [-0.202829( ± 0.0644588)] +AE [-
3.30672e-005( ± 2.35304e-005)]   
Contribution of parameters to model is :           Q: R: 
AE:: 2.49915:1.72252:1 
n=28,r=0.898438,r^2=0.80719,variance=0.0199388,s
td=0.141205,F=33.4917,FIT=275.425 
 
Training-test set equation: 
 
 
 
 
 
 
 
BA = [6.3109( ± 0.262132)] +Q [0.0627601( ± 
0.0172347)] +R [-0.202202( ± 0.0677932)] +AE [-
3.57432e-005( ± 2.33371e-005)]   
n=23,r=0.906716,r^2=0.822135,variance=0.0177467,
std=0.133217,F=29.2741,FIT=280.135 
 
Model 2:  
Parent equation: 
BA = [6.24618( ± 0.26407)] +Q [0.0641464( ± 
0.0172144)] +R [-0.197591( ± 0.0637312)] +AF [-
0.000219438( ± 0.000163466)]   
Contribution of parameters to model is Q: R: AF:: 
2.67013:1.83056:1 
n=28,r=0.895931,r^2=0.802693,variance=0.0204039,
std=0.142842,F=32.546,FIT=267.648 
 
Training-test set equation: 
BA = [6.3126( ± 0.263128)] +Q [0.0617991( ± 
0.0169394)] +R [-0.198354( ± 0.0667528)] +AF [-
0.000244006( ± 0.000161255)]   
contribution of parameters to model is 
Q:R:AF::2.26356:1.81684:1 
n=23,r=0.905881,r^2=0.820621,variance=0.0178978,
std=0.133783,F=28.9736,FIT=277.259 
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10.  15.66 -4.26 -7.95 -3.51 
11.  15.11 -3.57 -8.35 -2.73 
12.  13.86 -2.85 -8.41 -2.80 
13.  12.48 -2.95 -8.49 -3.85 
14.  2 -6.73 -8.40 -4.45 
15.  21.64 -1.94 -9.35 -3.23 
16.  22.61 -1.92 -9.31 10.91 
17.  22.59 -1.94 -9.43 -1.67 
18.  22.62 -1.91 -9.36 -3.85 
19.  22.97 -1.92 -9.36 11.25 
20.  6.02 -1.87 -9.11 1.74 
21.  9.88 -2.60 -8.87 11.03 
22.  9.92 -2.56 -8.61 7.71 
23.  9.93 -2.57 -8.53 10.72 
24.  9.89 -2.57 -8.73 10.21 
25.  10.20 -2.70 -8.98 -2.99 
26.  10.22 -2.69 -8.96 -3.30 
27.  10.26 -2.69 -8.73 -2.19 
28.  10.58 -2.81 -8.65 -1.56 
29.  10.43 -2.67 -8.77 -5.60 
IAJPS 2018, 05 (01), 42-51          Sushil kumar sah and Birendra S               ISSN 2349-7750 
 
www.iajps.com Page 46 
 
Table 3: Observed, Calculated and Predicted pMIC values of Training Set Compounds using 3D-QSAR 
Equation for model 1: 
  
Compounds Observed  pMIC Calculated  pMIC Predicted pMIC 
1.  7.53 7.58 7.60 
2.  6.79 6.96 7.02 
3.  7.75 7.77 7.77 
4.  7.77 7.90 7.94 
5.  7.77 7.69 7.68 
6.  7.32 7.35 7.36 
7.  7.2 7.41 7.45 
8.  7.28 7.17 7.16 
9.  7.33 7.24 7.23 
10.  7.49 7.56 7.58 
11.  7.83 7.73 7.72 
12.  7.17 6.94 6.89 
13.  7.19 7.30 7.56 
14.  7.77 7.71 7.70 
15.  7.32 7.24 7.24 
16.  7.21 7.24 7.24 
17.  7.77 7.68 7.67 
18.  7.32 7.21 7.20 
19.  6.95 7.22 7.24 
20.  7.79 7.64 7.62 
21.  7.31 7.33 7.33 
22.  7.24 7.17 7.15 
23.  7.19 7.26 7.27 
 
 
 
Fig.1: Discrete Plot of observed vs. calculated pMIC values by leave-one-out cross-validation for model 1: 
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Fig.2: Discrete Plot of observed vs. predicted pMIC values by leave-one-out cross-validation for model 1: 
 
Table 4: Observed and Predicted pMIC values of Test Set Compounds using 3D-QSAR Equation for model 
1: 
Compounds Observed  pMIC Predicted pMIC 
1.  7.51 7.53 
2.  6.94 7.18 
3.  7.79 7.69 
4.  7.86 7.57 
5.  7.53 7.58 
 
 
Fig.3 Discrete Plot of observed vs. predicted pMIC values by leave-one-out cross-validation for model 1. 
 
Table 5: Observed, Calculated and Predicted pMIC values of Training Set Compounds using 3D-QSAR 
Equation for model 2: 
 
Compounds Observed  pMIC Calculated  pMIC Predicted pMIC 
1.  7.53 7.57 7.59 
2.  6.79 6.95 7.01 
3.  7.75 7.77 7.77 
4.  7.77 7.90 7.93 
5.  7.77 7.69 7.68 
6.  7.32 7.35 7.36 
7.  7.2 7.42 7.45 
8.  7.28 7.18 7.17 
9.  7.33 7.25 7.24 
10.  7.49 7.57 7.59 
11.  7.83 7.70 7.69 
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12.  7.17 6.94 6.88 
13.  7.19 7.30 7.57 
14.  7.77 7.71 7.70 
15.  7.32 7.26 7.25 
16.  7.21 7.24 7.24 
17.  7.77 7.69 7.68 
18.  7.32 7.21 7.20 
19.  6.95 7.22 7.24 
20.  7.79 7.65 7.63 
21.  7.31 7.32 7.32 
22.  7.24 7.15 7.13 
23.  7.19 7.27 7.28 
 
 
Fig. 4: Discrete Plot of observed vs. calculated pMIC values by leave-one-out cross-validation for model 2. 
 
 
 
 
Fig.5: Discrete Plot of observed vs. predicted pMIC values by leave-one-out cross-validation for model 1: 
 
Table 6: Observed and Predicted pMIC values of Test Set Compounds using 3D-QSAR Equation for model 
2: 
 
Compounds Observed  pMIC Predicted pMIC 
1.  7.51 7.55 
2.  6.94 7.17 
3.  7.79 7.69 
4.  7.86 7.54 
5.  7.53 7.57 
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Fig.6: Discrete Plot of observed vs. predicted pMIC values by leave-one-out cross-validation for model 2. 
 
Validation of models: 
 Once the equation is obtained, it is important to determine its reliability and significance. The validation of the 
equation is done by cross-validation /leave-one out method. The results are shown below. 
Table 7: Validation of models: 
 
Model no. I II 
N 23 23 
R 0.906 0.905 
r2 0.822 0.820 
Variance 0.017 0.017 
Std 0.133 0.133 
F 29.274 28.973 
FIT 280.135 277.259 
Q2 0.691 0.687 
SDep 0.159 0.160 
Spress 0.175 0.176 
r2 pred 0.702 0.684 
Chance <0.001 <0.001 
 
In the above QSAR models n is the number of data 
points, r is correlation coefficient, r2
 
is squared 
correlation coefficient, std is standard deviation or 
standard error of estimate, Accuracy in the analysis is 
shown by low values of standard error of estimate. F 
represents Fischer ratio between the variances of 
calculated and observed activities.  The correlation 
coefficient value (r=0.906 for model 1 and r=0.905, 
for model 2) represents the better fit of the regression 
and good predictive ability and robustness of the 
model. Both of the models have significance level 
better than the 99.95% as it exceeded the tabulated 
F=29.27 and F= 28.97 for model 1 &2 respectively. 
Very low SPRESS and SDEP of the models indicate 
predictivity of the models. Low standard error of 
estimation (std=0.133 for model 1 and std=0.133, for 
model 2) suggests a high degree of confidence in 
model. Chance is the ratio of the equivalent 
regression equations to the total number of 
randomized sets; (chance value of 0.001 corresponds 
to 0.1% chance of fortuitous correlation). 
In model I & II stretch energy contributed positively 
to the biological activity whereas dipole- dipole 
energy contributed negatively to the biological 
activity. HOMO energy and Non-1, 4 VDW Energy 
contributed negatively to the biological activity in 
model I & II respectively. Stretch energy is the 
thermodynamic parameter that deals with 
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conformational flexibility of molecule. Negative 
contribution of stretch energy suggests that 
substituent that decrease the flexibility of nucleus 
will enhance the activity. The dipole- dipole energy 
descriptor in the models represents the sum of 
electrostatic terms resulting from the interaction of 
two dipoles. The descriptor bears a positive 
coefficient, which suggests significance of dipole–
dipole interactions for the antibacterial activity which 
means increase in magnitude of dipole-dipole 
interaction will increase the activity of compounds. 
HOMO is an electronic descriptor and represents the 
highest energy level in the molecule that contains 
electron pairs. HOMO represents ability to donate 
electrons.  It is important in governing molecular 
reactivity and properties and measures the 
nucleophilicity of the molecule. Negative 
contribution suggested that molecule will interact on 
electron rich areas on receptor and the substitution of 
electron withdrawing groups in the molecule will 
impart the positive influence on activity. Non-1, 4 
VDW Energy is the energy for the through space 
interaction between pairs of atoms that are separated 
by more than three atoms. Negative contribution of 
Non-1, 4 VDW Energy (attractive force between 
active substituent and enzyme binding sites) in 
biological activity indicates that minimizing 
parameters with suitable substituent enhance the 
activity. Thus aryl substituent may increase activity 
while alkyl or bulky groups may decrease activity.  
 
 
Fig. 7: Stereo view of the molecular rectangular field grid around the superposed molecular units of 
triazolothiadiazole derivative series of compounds using SW kNN MFA method (Alignment of the molecules) 
 
Fig. 8: Contributions of descriptors for biological activity developed using SW-kNN-MFA equation for 3D 
QSAR. 
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CONCLUSIONS: 
QSAR analysis was performed on a series of 
triazolothiadiazoles using molecular modeling 
program Chemoffice2001. QSAR models were 
proposed for antimicrobial activity of the 
thiadiazinoacridines using ChemSAR descriptors 
employing sequential multiple regression analysis 
method. The predictive power of each model was 
estimated with boot strapping r2 method and leave–
one–out cross validation method. It was observed 
from the selected models that biological activity of 
triazolothiadiazoles is governed by thermodynamic 
and electronic properties of the molecules. 
Findings of present study reveal that substituent those 
decrease the flexibility of molecule results in increase 
in antimicrobial potency, aryl substituent would 
enhance the antimicrobial activity of compounds and 
presence of electron withdrawing group in structure 
is favorable for antibacterial activity of 
triazolothiadiazoles. The finding of the study will be 
helpful in the design of potent analogues of 
triazolothiadiazoles. Finally, it is hoped that the work 
presented here will play an important role in 
understanding the relationship of physiochemical 
parameters with structure and biological activity. By 
studying the QSAR model one can select the suitable 
parameter for designing active compound for 
antimicrobial activity with maximum potency. 
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